The results of a nine-country survey released today indicate that over 40% of respondents do not understand that AIDS is always a fatal disease. Reuters Health Information
Companies can save money and retain more staff by offering their workers HIV programmes, particularly in areas where infection rates are high, an international aid agency said on Tuesday. Reuters Health Information
Co-administration of a plasmid encoding optimized IL-15 with a DNA vaccine can enhance suppression of simian-HIV (SHIV) replication, according to a report in the November 12th Early Edition of the Proceedings of the National Academy of Sciences. Reuters Health Information
The LMB86 chemotherapy regimen is highly effective against AIDS-related Burkitt lymphoma with bone marrow and/or central nervous system involvement, according to a new study -- if patients have relatively high CD4 counts and good performance status. Reuters Health Information
In women given intrapartum nevirapine for prevention of perinatal HIV transmission, a single dose of tenofovir and emtricitabine can reduce the development of HIV resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) at 6 weeks post-delivery, new research shows. Reuters Health Information
AIDS-defining morbidity and mortality have so dramatically decreased since 1996 that using these measures alone can no longer be used to describe HIV disease progression in the era of combination ART. HIV Medicine
Nevirapine-containing HAART response varies by CYP2B6-G516T genotype in children, which becomes an important consideration in clinical response for young patients with HIV/AIDS. AIDS
Fibrosis progression in HIV and Hepatitis C co-infected individuals is documented in a study of predominantly African American adult men, even with treatment for HIV or HCV, confirmed with biopsies. AIDS
Adapting antiretroviral therapy (ART) for direct administration poses challenges. Might monitored dosing of ART be feasible and successful in improving treatment response in HIV-infected drug users? AIDS Clinical Care
Risk for sudden infant death syndrome (SIDS) is 69 times higher for babies of HIV-positive women who used opiates during pregnancy than in the general population of similarly aged infants, Swiss researchers report in the November issue of the Archives of the Disease in Childhood. Reuters Health Information
